{"result": "(\"entity\"<|>AMERICAN JOINT COMMITTEE ON CANCER<|>ORGANIZATION<|>The American Joint Committee on Cancer (AJCC) is an organization that provides cancer staging guidelines and classifications, including the 8th edition of the TNM classification system.)\n##\n(\"entity\"<|>ATA<|>ORGANIZATION<|>The ATA (American Thyroid Association) is an organization that provides guidelines and recommendations for the management of thyroid diseases, including risk assessment for thyroid cancer.)\n##\n(\"entity\"<|>THYROID CANCER<|>EVENT<|>Thyroid cancer is a type of cancer that affects the thyroid gland, and its staging and management are guided by organizations like the AJCC and ATA.)\n##\n(\"entity\"<|>PATIENT<|>PERSON<|>A patient undergoing assessment and treatment for thyroid cancer, whose risk of recurrence is evaluated according to the ATA guidelines.)\n##\n(\"relationship\"<|>PATIENT<|>THYROID CANCER<|>The patient is being assessed for thyroid cancer, which is the condition they are facing<|>8)\n##\n(\"relationship\"<|>AMERICAN JOINT COMMITTEE ON CANCER<|>THYROID CANCER<|>The AJCC provides the staging guidelines for thyroid cancer, influencing how it is classified and treated<|>7)\n##\n(\"relationship\"<|>ATA<|>THYROID CANCER<|>The ATA provides guidelines for the management and risk assessment of thyroid cancer<|>7)\n##\n(\"relationship\"<|>PATIENT<|>ATA<|>The patient's risk of recurrence is evaluated according to the guidelines set forth by the ATA<|>6)\n##\n(\"relationship\"<|>PATIENT<|>AMERICAN JOINT COMMITTEE ON CANCER<|>The patient's cancer staging may be influenced by the classifications provided by the AJCC<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: oxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome? Endocr Relat\n                 Cancer. 2011;18:159-69.                                                                                                                           COMENTARIO\n               • Leboulleux S, Schroeder PR, Busaidy NL, Auperin A, Corone C, Jacene HA, et al. Assessment of the incremental value of recombinant\n                 thyrotropin stimulation before 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to\n                 localize residual differentiated thyroid cancer. J Clin Endocrinol Metab. 2009;94:1310-6.                                                         En relación con el caso clínico que precede a la pregunta, el tumor tiene 3,9 cm de diámetro,\n                                                                                                                                                                   por lo que se trata de un T2 y al tener metástasis ganglionares a nivel del compartimento VI\n                                                                                                                                                                   se trata de un N1a. Dado que no hay metástasis a distancia, se trata de un M0: T2 N1a M0.\n     3.7 Miscelánea                                                                                                                                                A la hora de estadificarlo, con las características antes citadas, la 8.ª edición de la AJCC\n                                                                                                                                                                   (American Joint Commitee on Cancer) ha elevado el corte de edad de riesgo de 45 a 55 años,\n                                                                                                                                                                   por  lo  que este      paciente, con 50         años,   baja de     un TNM      III que tendría       con la    clasificación\n        45     En   qué situación no está aumentada la TBG                          (proteína transportadora de tiroxina):                                         antigua a un       TNM I con esta nueva clasificación.\n               A. Toma de estrógenos.                                                                                                                              Igualmente, ha desaparecido en esta nueva edición la inclusión de “mínima extensión ex-\n               B. Embarazo.                                                                                                                                        tratiroidea”, por lo que, aunque la presente el paciente descrito, no se valora a la hora de la\n               C. Toma de andrógenos anabolizantes.                                                                                                                clasificación TNM.\n               D.   Neonatos.                                                                                                                                      Por tanto, la respuesta correcta a la pregunta es la opción B.\n                                                                                                                                                                   Tabla 5. Clasificación TNM, 8.ª edición de la AJCC\n               COMENTARIO\n               Las hormonas tiroideas circulan en sangre unidas a una proteína trasportadora (TBG). Esta                                                                                   Estadio I             Cualquier T y N                                        M0\n               globulina es producida por el hígado y sus niveles están influidos por una serie de factores.                                                           <55 años            Estadio II            Cualquier T y N                                        M1\n               El más importante de ellos son los estrógenos, que estimulan su síntesis por los hepatoci-\n               tos, de forma que, en las situaciones de hiperestrogenismo, como es la toma de estrógenos                                                                                   Estadio I             T1 o T2                      N0                        M0\n               o  el embarazo, la TBG puede duplicar sus valores normales (opciones A y B son ciertas).                                                                                    Estadio II            T1 o T2                      N1a/b M0\n               En   el neonato,      los valores     de TBG      se encuentran elevados,             tanto en los nacidos          a término                                                                     T3 a/b                       Cualquier N               M0\n               como en los pretérmino o pequeños para su edad gestacional (opción D cierta).                                                                           >55 años            Estadio III           T4a                          Cualquier N               M0\n               La afirmación        errónea es la      contenida en la opción C. En efecto, los andrógenos, al                         contra-                                             Estadio IVA           T4b                          Cualquier N               M0\n               rio que los      estrógenos, disminuyen la producción hepática                        de TBG, por       lo que sus valores                                                  Estadio IVB           Cualquier T y N                                        M1\n               disminuyen durante la toma de andrógenos anabolizantes.                                                                                             Fuente: Amin MB et al. AJCC Cancer Staging Manual. 8.ªed. New York: Springer; 2017.\n               Referencias:\n               • Jacobsen BB, Hummer L. Changes in serum concentrations of thyroid hormones and thyroid hormone-binding proteins during early infancy.             Referencias:\n                 Studies in healthy fullterm, small-for-gestational age and preterm infants aged 7 to 240 days. Acta Paediatr Scand. 1979;68(3):411-8.             • Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8.ª ed. New York: Springer, 2017.\n\n\n\n184                                                                                                                                                                                                                                                                                                    185\n---\n                                                                                                                                                                                                                                                 TIROIDES                         3\n\n\n\n     47  En este paciente, el riesgo de recurrencia según la Guía ATA 2015 sería:                                                                48     Durante el seguimiento de este paciente se detecta una elevación de anticuerpos\n         A. ATA riesgo bajo.                                                                                                                            antitiroglobulina (Ac. anti-Tg). ¿Ante qué tipo de\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}